Navigation Links
Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
Date:10/26/2008

d Haemophilus influenzae and a once-a-day option at a significantly lower dose than linezolid. Additionally, these results further validate Rib-X's proprietary discovery and development approach which led to the identification of this compound as well as multiple other novel compounds in various classes which are able to circumvent bacterial resistance mechanisms."

Study Results

The poster, entitled "A Phase 2 Study Comparing Two Doses of Radezolid to Linezolid in Adults with Uncomplicated Skin and Skin Structure Infections (uSSSI)," reported that clinical cure rates with a 95% confidence interval in clinically evaluable patients were 97.4% for patients treated with radezolid at a dosage of 450 mg once a day (38/39); 94.4% for patients treated with radezolid 450 mg twice a day (36/39); and 97.4% for patients treated with linezolid 600 mg twice a day (37/38).

Clinical cure rates among clinically evaluable patients with confirmed MRSA infections with a 95% confidence interval were 100% and 92.9% for patients treated with radezolid once a day (8/8) and twice a day (13/14), respectively, and 93.3% for patients treated with linezolid 600 mg twice a day (14/15). In microbiologically evaluable patients, eradication was achieved in 100% of the group treated with radezolid at 450 mg once a day (20/20), and 87.5% in the group receiving radezolid 450 mg twice daily (21/24), versus 91.3% in the group receiving linezolid 600 mg twice daily (21/23).

uSSSI Phase 2 Trial Design

This Phase 2 trial, which enrolled 150 patients, was a multicenter, randomized, open-label, comparative study conducted at 19 clinical centers across the U.S. to evaluate the safety and efficacy of radezolid versus linezolid in the outpatient treatment of adult patients with uncomplicated skin and skin structure infections (uSSSI). The study assessed the efficacy of a 450mg dose of radezolid given orally, either once daily or twice daily for five to ten days compared to a 6
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
2. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
3. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
4. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... and KING OF PRUSSIA, Pa. , May ... has awarded CSL Behring its 2015 Corporate Leadership ... to advancing science and improving the care of the bleeding ... , CEO and Managing Director, CSL Limited, during the NHF ... on May 21. "The National Hemophilia Foundation ...
(Date:5/22/2015)... According to a new market research report ... by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), ... - Global Forecast to 2020", published by MarketsandMarkets, the global ... Million by 2020 from $452.36 Million in 2015, growing ... 71 market data Tables and 90 Figures spread through ...
(Date:5/22/2015)... DUBLIN , May 22, 2015 Research ... announced the addition of the "Latest Regulations ... report to their offering. This ... officially issued a guidance on international multi-center clinical ... , which has begun to be implemented on ...
Breaking Medicine Technology:National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... Technologies Inc. (OTCBB: MDCE), a children,s healthcare service provider, ... common stock held on February 29, 2012 at 10:00 a.m. ... Meeting will occur on March 29, 2012 at 10:00 a.m. ... ensure that their voting instructions are carried out on proposed ...
... SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... 7)*REPLIGEN CORP (Name of Issuer)Common Stock, Par Value $0.01 Per ... Barry L. Fischer Thompson Coburn LLP 55 East ... Address and Telephone Number of Person Authorized to Receive Notices ...
Cached Medicine Technology:Medical Care Technologies Inc. Announces Adjournment of Special Meeting 2Medical Care Technologies Inc. Announces Adjournment of Special Meeting 3Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D 2Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D 3Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D 4Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D 5
(Date:5/25/2015)... Iowa City, Iowa (PRWEB) May 25, 2015 ... Engineering Excellence awards for design of the ... in Iowa City, Iowa.    The project received a National Recognition ... and an Honor Award from ACEC – Iowa. ... outstanding engineering achievements. , The $50.2 million expansion is ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Join Fiona's Soccer ... free two-hour instructional clinic. Irish National Player, Fiona O'Sullivan ... give them a taste of her coaching style. Fiona has ... Novato. Camps in Novato are at Lynwood Elmentary School (June ... Novato High School - June 6th, 2015 - 1:00-3:00pm. Bring ...
(Date:5/25/2015)... Burke Rehabilitation Hospital will welcome ... New York City, to speak at Burke on Wednesday, June ... Legacy Lobby Lecture series, will take place at 4:30 p.m. ... great grandson of Stanford White of McKim, Mead and White, ... campus 100 years ago. , “We are thrilled to welcome ...
(Date:5/24/2015)... The Rolling Stones Zip Code summer stadium ... Petco Park. This iconic group is ready for their ... had a warmup show in Los Angeles at the Henry ... this beloved band not only played their Sticky Fingers album ... "Jumping Jack Flash," "Moonlight Mile" and "All Down the ...
(Date:5/24/2015)... Michigan (PRWEB) May 24, 2015 ... them to take pressure measurements in patients’ bladder and ... doctor usually orders it if they have reported symptoms ... , Women’s Excellence in Bladder Control is ... unwanted urinary leakage or problems with overall control of ...
Breaking Medicine News(10 mins):Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2
... without diabetes face 4-fold increase in death, major complications ... proper blood sugar levels after heart surgery is essential, ... study shows. , The British report, published ... control in post-heart surgery patients is linked to a ...
... Chauncey Billups of the Detroit Pistons, DETROIT, July ... 24th Annual Celebrity Golf Classic is just around the,corner ... Club., The day is sure to be fun ... official shotgun start at 11:00 a.m. Highlights of the,event ...
... Expert in International Health Economics and Financing and Health ... Will Play Leading Role in Health Systems 20/20 Project, ... that,Dr. Hong Wang, M.D., Ph.D., has joined the company ... Systems 20/20 project, which is,the USAID Bureau of Global ...
... The Lance Armstrong Foundation,(LAF) is pleased to announce that ... its second LIVESTRONG(TM) Summit., "Cancer will soon be the ... to know how our leaders plan to combat it," said ... accepted,our invitation to talk about his plans to further the ...
... and Partnership with CDC, CAMBRIDGE, Mass., July ... assistance firm, this month opened an Atlanta,office designed ... U.S. Centers for Disease Control and Prevention (CDC)., ... of our firm for many years,",said Kathleen Flanagan, ...
... Biological Psychiatry is particularly proud to announce ... of the National Institute of Mental Health (NIMH) Cognitive ... Schizophrenia, or CNTRICS, initiative. This July 1, 2008 ... overview paper of the CNTRICS meeting, and six review ...
Cached Medicine News:Health News:Poor Blood Sugar Control After Heart Surgery Impacts Outcomes 2Health News:Come Tee-Up at The Children's Center 24th Annual Celebrity Golf Classic! 2Health News:Leading Health Economist, Dr. Hong Wang, Joins Abt Associates 2Health News:Leading Health Economist, Dr. Hong Wang, Joins Abt Associates 3Health News:Lance Armstrong Foundation to Welcome Senator John McCain to LIVESTRONG(TM) Cancer Summit 2Health News:Abt Associates Opens Atlanta Office 2Health News:Aiming to improve schizophrenia treatment through the NIMH CNTRICS Initiative 2Health News:Aiming to improve schizophrenia treatment through the NIMH CNTRICS Initiative 3
... safe care environment by automatically bar code printing ... level. The automated process and reliable bar codes ... of all items, including vials, ampules, syringes, IV ... saves valuable time for pharmacy staff and helps ...
wBloodCare™ provides functionality at the bedside to ensure that the correct patient receives the correct blood product....
Specimen-ID™, a Positive Specimen Identification System, assures the permanent link at the bedside between patient and laboratory specimen to prevent sample identification errors....
wCareMed™ utilizes barcode scanning technology to support medication administration. It is a simple to use point of care application that provides access to patient information on a lightweight,...
Medicine Products: